REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07527910 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-20 → 2026-05-22 3. completion date: 2029-11-27 → 2030-03-15 4. primary completion date: 2029-11-27 → 2030-03-15
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical